Posts
Media
Videos
Starter Packs
Two vaccine candidates using mRNA technology elicit a potent immune response against HIV
go.nature.com/4ov7WZI
go.nature.com/4ov7WZI
mRNA vaccines for HIV trigger strong immune response in people
Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.
go.nature.com
Reposted
Atul Gawande
@agawande.bsky.social
· Jun 28
A recent study devised forecasts for the next 25 years if vaccination rates decline by various rates. A ten-per-cent drop in measles vaccination, for example, would lead to some 11 million additional cases.
Calculating the Damage of Vaccine Skepticism
It’s clear that we’re on the precipice of a surge in preventable diseases. But how bad will it get?
www.newyorker.com